跳至主要内容
临床试验/NCT07744607
NCT07744607已完成不适用

Clinical Validity Verification on Diagnostic Assistance for Presence and Severity of Colorectal Cancer and Polyps Using Artificial Intelligence-Based Medical Device Software for Endoscopic Imaging Assistance: A Single-Center, Single-Arm, Retrospective, Confirmatory Clinical Trial

Ainex Corporation1 个研究点 分布在 1 个国家目标入组 1,114 人开始时间: 2025年1月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,114
试验地点
1
主要终点
Clinical Specificity for Sessile Serrated Lesions

研究概览

简要总结

This completed retrospective study evaluated the clinical performance of ENAD-CADx-01, an artificial intelligence-based medical device software intended to assist healthcare professionals in characterizing colorectal lesions in colonoscopy images. Previously collected colonoscopy images and corresponding histopathological results from Asan Medical Center were analyzed. The performance of ENAD-CADx-01 was evaluated based on its sensitivity, specificity, and overall accuracy in classifying colorectal lesions as neoplasm, hyperplastic polyp, or sessile serrated lesion. No participants were prospectively enrolled, and no study-related intervention was performed.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants aged 18 years or older at the time of colonoscopy.
  • Participants who underwent colonoscopy at Asan Medical Center and had colorectal lesion images available for retrospective analysis.
  • Participants with corresponding histopathological results available as the reference standard.
  • Colonoscopy images that met the predefined image quality requirements for analysis by ENAD-CADx-01.

排除标准

  • Participants without corresponding histopathological results for the colorectal lesion.
  • Images with insufficient quality for analysis, including severe blur, obstruction, or inadequate visualization of the lesion.
  • Images or records with missing or insufficient data required for the clinical performance analysis.
  • Lesions that did not meet the predefined target lesion categories or other eligibility requirements specified in the clinical investigation plan.

结局指标

主要结局

Clinical Specificity for Sessile Serrated Lesions

时间窗: Up to 4 weeks

Clinical Sensitivity for Neoplasm

时间窗: Up to 4 weeks

Clinical Specificity for Neoplasm

时间窗: Up to 4 weeks

Clinical Sensitivity for Hyperplastic Polyps

时间窗: Up to 4 weeks

Clinical Specificity for Hyperplastic Polyps

时间窗: Up to 4 weeks

Clinical Sensitivity for Sessile Serrated Lesions

时间窗: Up to 4 weeks

次要结局

未报告次要终点

研究者

发起方
Ainex Corporation
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Clinical Validity Verification on Diagnostic... | 临床试验